TY - JOUR
T1 - Quality indicators of stroke care in Colombia based on the RES-Q registry
AU - RES-Q Colombia registry
AU - Bayona, Hernán
AU - Amaya, Pablo
AU - Bustos, José Luis
AU - Giraldo-Tapias, Liliana M.
AU - Betancourt, Andrés
AU - Vallejo, Catalina
AU - Rivillas, Julián
AU - Llanos-Leyton, Natalia
AU - Mantilla, Katherine
AU - Fabián Álvarez, Tony
AU - Martinez, Carlos
AU - Orozco, Jaime Eduardo Rodriguez
AU - Jimenez, Claudio
AU - Torres, Javier
AU - Isaza, Carolina
AU - Coral, Juliana
AU - Patiño-Rodriguez, H. Mauricio
AU - Macareno, Hugo
AU - Mantilla, Daniel
AU - Corredor-Quintero, Ángel Basilio
AU - Urbina, Zulma
AU - de la cruz, Liliana
AU - Mejía, Juan Guillermo
AU - Martinez, Viviana
AU - Silva, Miguel
AU - Afonso chavarro, Luis
AU - Revelo, Jorge
AU - Márquez, Benjamin
AU - Aroca, Alexander
AU - Lopez, Sandra Jurado
AU - Gómez-Mesa, Diana
AU - Tobón, Jóse Vladimir
AU - Jiménez, Daniela
AU - Silva, Federico
AU - Perez-Romero, Germán E.
AU - Muñoz-Collazos, Mario
N1 - Publisher Copyright:
© 2025
PY - 2025/5
Y1 - 2025/5
N2 - Objectives: This study seeks to outline the epidemiological patterns and quality of care indicators of ischemic stroke in Colombia. It serves as a pioneering effort, offering crucial national-level insights to inform evidence-based stroke policies in Colombia. Materials and Methods: Using data from the Registry of Stroke Care-Quality (RES-Q) spanning the years 2017 to 2021, a multicenter descriptive study was conducted in Colombia. A survival analysis using Kaplan-Meier curves was planned for the time from symptom onset to hospital arrival, hospital stay and mortality, stratified by pre-established geographic regions. Results: A total of 7,963 patients were included in 4 geographic regions: Amazon, Andean, Caribbean and Pacific. The main data provider was the Andean region with 6,402 patients (80.3 %). 49 % were women. The median age was 72 years (IQR 61-81). The NIHSS scale was a median of 7 IQR (3-15). 14.5 % (994) received intravenous thrombolysis therapy. The door to needle time was 53 min IQR (36-70). 53 % were hospitalized in a standard bed, 41 % in intensive care/stroke unit. 33.4 % patients had a Rankin score at discharge between 0-2. Conclusion: First study conducted using RES-Q data at the national level in Colombia. A reduction of door-to-needle times by at least 50 % compared to historical levels is evident. Low reperfusion rates persist. Secondary prevention measures are needed with the implementation of national stroke policies.
AB - Objectives: This study seeks to outline the epidemiological patterns and quality of care indicators of ischemic stroke in Colombia. It serves as a pioneering effort, offering crucial national-level insights to inform evidence-based stroke policies in Colombia. Materials and Methods: Using data from the Registry of Stroke Care-Quality (RES-Q) spanning the years 2017 to 2021, a multicenter descriptive study was conducted in Colombia. A survival analysis using Kaplan-Meier curves was planned for the time from symptom onset to hospital arrival, hospital stay and mortality, stratified by pre-established geographic regions. Results: A total of 7,963 patients were included in 4 geographic regions: Amazon, Andean, Caribbean and Pacific. The main data provider was the Andean region with 6,402 patients (80.3 %). 49 % were women. The median age was 72 years (IQR 61-81). The NIHSS scale was a median of 7 IQR (3-15). 14.5 % (994) received intravenous thrombolysis therapy. The door to needle time was 53 min IQR (36-70). 53 % were hospitalized in a standard bed, 41 % in intensive care/stroke unit. 33.4 % patients had a Rankin score at discharge between 0-2. Conclusion: First study conducted using RES-Q data at the national level in Colombia. A reduction of door-to-needle times by at least 50 % compared to historical levels is evident. Low reperfusion rates persist. Secondary prevention measures are needed with the implementation of national stroke policies.
KW - Epidemiology
KW - Health Policy
KW - Mechanical Thrombolysis
KW - Stroke
KW - Thrombolytic Therapy
UR - http://www.scopus.com/inward/record.url?scp=85218947161&partnerID=8YFLogxK
U2 - 10.1016/j.jstrokecerebrovasdis.2025.108249
DO - 10.1016/j.jstrokecerebrovasdis.2025.108249
M3 - Artículo Científico
C2 - 39921199
AN - SCOPUS:85218947161
SN - 1052-3057
VL - 34
JO - Journal of Stroke and Cerebrovascular Diseases
JF - Journal of Stroke and Cerebrovascular Diseases
IS - 5
M1 - 108249
ER -